Citation Impact
Citing Papers
The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring
2016 StandoutScience
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
The UK Biobank resource with deep phenotyping and genomic data
2018 StandoutNature
Quantitative analysis of human blood serum using vibrational spectroscopy
2020
Homocysteine and vascular disease
1999 Standout
Risk Factors for Vascular Disease and Dementia
1998
Pericytes are required for blood–brain barrier integrity during embryogenesis
2010 StandoutNature
Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam scan study
2002
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study
1998
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Statins and the risk of dementia
2000
Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study
2001
Stroke and the Risk of Alzheimer Disease
2003
Apolipoprotein E Polymorphism and Alzheimer Disease
2000
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
2002 Standout
Association between features of the insulin resistance syndrome and alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study
1997
Developmental and vascular risk factors for Alzheimer's disease
2004
The controversy over homocysteine and cardiovascular risk
2000
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
2005 Standout
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Dietary Intake of Antioxidants and Risk of Alzheimer Disease
2002
The need for research on dementia in developing countries
1997
The Homocysteine Hypothesis of Depression
2007
Trans Fatty Acids and Cardiovascular Disease
2006 Standout
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
1998 Standout
Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study
2004
Leisure Activities and the Risk of Dementia in the Elderly
2003 Standout
Global prevalence of dementia: a Delphi consensus study
2005 Standout
The protocols for the 10/66 dementia research group population-based research programme
2007
Prevention of stroke and dementia with statins
2003
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Homocysteine and cardiovascular disease: cause or effect?
2000
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
2006 Standout
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study
2001
MTHFR 677C→T Polymorphism and Risk of Coronary Heart Disease
2002
Neurovascular mechanisms of Alzheimer's neurodegeneration
2005
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Incidental Findings on Brain MRI in the General Population
2007 Standout
Diabetic Retinopathy
2012 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Fibrinogen polymorphisms are not associated with the risk of myocardial infarction
2000
Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel
2004
Circle of Willis atherosclerosis: association with Alzheimer’s disease, neuritic plaques and neurofibrillary tangles
2006
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
2003 Standout
Type 2 diabetes mellitus, cognitive impairment and dementia
1999
Homocysteine and Risk of Ischemic Heart Disease and Stroke
2002 Standout
Vascular cognitive impairment
2003 Standout
Detecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and Pitfalls
2004
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
2004 Standout
Apolipoprotein E Genotype, Vascular Risk and Early Cognitive Impairment in an African Caribbean Population
2001
Vascular risk factors for Alzheimer’s disease:
2000
Polycystic Ovary Syndrome
2005 Standout
Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam study
1998
Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease
1998 Standout
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial
2003
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 Standout
Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk
2004
Alzheimer's Disease
2010 Standout
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
2003 Standout
Major Depressive Disorder
2008 Standout
Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls
2002
Tissue‐type plasminogen activator and C‐reactive protein in acute coronary heart disease. A nested case–control study
2000
Homocysteine and cardiovascular disease:
2002
Longitudinal Assessment of Neurocognitive Function after Coronary-Artery Bypass Surgery
2001 Standout
Midlife blood pressure and dementia: the Honolulu–Asia aging study☆
2000
Global diets link environmental sustainability and human health
2014 StandoutNature
AGING, MILD COGNITIVE IMPAIRMENT, AND ALZHEIMER'S DISEASE
2000
Plasma total homocysteine concentration and the risk of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Studytpdel
2000
Alzheimer's Disease
2004 Standout
Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins
2004
Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies
2002
The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease
2004
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors
2008 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Alzheimer's disease: the cholesterol connection
2003
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank - rationale, challenges and approaches
2013
Molecular Mechanisms of Amyloidosis
2003 Standout
Delirium in Older Persons
2006 Standout
Cerebral microvascular pathology in aging and Alzheimer's disease
2001
How do heart disease and stroke become risk factors for Alzheimer's disease?
2006
Do Delirium and Alzheimer’s Dementia Share Specific Pathogenetic Mechanisms?
1999
Homocyst(e)ine, Diet, and Cardiovascular Diseases
1999
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2007 Standout
Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial
2008
Hyperhomocysteinemia Is Associated With an Increased Risk of Cardiovascular Disease, Especially in Non–Insulin-Dependent Diabetes Mellitus
1998
Folates and Cardiovascular Disease
2002
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
2002 StandoutScience
Variable Impact of Combining Fatal and Nonfatal End Points in Heart Failure Trials
2006
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
PLEIOTROPIC EFFECTS OF STATINS
2004 Standout
Homocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow up
2001
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
2006 Standout
Will a Healthy Lifestyle Help Prevent Alzheimer's Disease?
2003
Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo
2001
Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence
1999
Effect of Dietary Patterns on Serum Homocysteine
2000
Meat consumption, health, and the environment
2018 StandoutScience
Red Meat Consumption and Mortality
2012
Homocysteine and Cardiovascular Disease
1998 Standout
Prospective Study of Coronary Heart Disease Incidence in Relation to Fasting Total Homocysteine, Related Genetic Polymorphisms, and B Vitamins
1998
Diabetes mellitus and the risk of dementia
1999 Standout
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
Major Dietary Protein Sources and Risk of Coronary Heart Disease in Women
2010
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial
2003
Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.
2003
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Relationship Between ApoE, MRI Findings, and Cognitive Function in the Cardiovascular Health Study
1998
The immune response in autism: a new frontier for autism research
2006
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Works of Diederick E. Grobbee being referenced
Methylenetetrahydrofolate Reductase 677 C/T Genotype and Cardiovascular Disease Mortality in Postmenopausal Women
2001
Dietary haem iron and coronary heart disease in women
2004
Do oral contraceptives increase blood pressure and serum total cholesterol in young women?
1990
Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study
1997
Implications of trial results: the potentially misleading notions of number needed to treat and average duration of life gained
2000
Homocysteine and Short-term Risk of Myocardial Infarction and Stroke in the Elderly
1999
Elevated Plasma Fibrinogen
1998
The 4G5G polymorphism in the gene for PAI-1 and the circadian oscillation of plasma PAI-1
2003
Plasma Total Homocysteine, B Vitamins, and Risk of Coronary Atherosclerosis
1997
Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study.
1999
Tissue Plasminogen Activator and Risk of Myocardial Infarction
1997
Plasminogen Activator Inhibitor 4G Polymorphism Is Associated With Decreased Risk of Cerebrovascular Mortality in Older Women
2000